217 related articles for article (PubMed ID: 37491482)
1. Plasma microRNA ratios associated with breast cancer detection in a nested case-control study from a mammography screening cohort.
Chiorino G; Petracci E; Sehovic E; Gregnanin I; Camussi E; Mello-Grand M; Ostano P; Riggi E; Vergini V; Russo A; Berrino E; Ortale A; Garena F; Venesio T; Gallo F; Favettini E; Frigerio A; Matullo G; Segnan N; Giordano L
Sci Rep; 2023 Jul; 13(1):12040. PubMed ID: 37491482
[TBL] [Abstract][Full Text] [Related]
2. A Signature of Four Circulating microRNAs as Potential Biomarkers for Diagnosing Early-Stage Breast Cancer.
Itani MM; Nassar FJ; Tfayli AH; Talhouk RS; Chamandi GK; Itani ARS; Makoukji J; Boustany RN; Hou L; Zgheib NK; Nasr RR
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34204158
[TBL] [Abstract][Full Text] [Related]
3. A five-miRNA panel in plasma was identified for breast cancer diagnosis.
Li M; Zou X; Xia T; Wang T; Liu P; Zhou X; Wang S; Zhu W
Cancer Med; 2019 Nov; 8(16):7006-7017. PubMed ID: 31568692
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA profiling in serum: Potential signatures for breast cancer diagnosis.
Zou X; Xia T; Li M; Wang T; Liu P; Zhou X; Huang Z; Zhu W
Cancer Biomark; 2021; 30(1):41-53. PubMed ID: 32894240
[TBL] [Abstract][Full Text] [Related]
5. Plasma-based microRNA signatures in early diagnosis of breast cancer.
Li X; Zou W; Wang Y; Liao Z; Li L; Zhai Y; Zhang L; Gu S; Zhao X
Mol Genet Genomic Med; 2020 May; 8(5):e1092. PubMed ID: 32124558
[TBL] [Abstract][Full Text] [Related]
6. Circulating miRNAs signature on breast cancer: the MCC-Spain project.
Gómez-Acebo I; Llorca J; Alonso-Molero J; Díaz-Martínez M; Pérez-Gómez B; Amiano P; Belmonte T; Molina AJ; Burgui R; Castaño-Vinyals G; Moreno V; Molina-Barceló A; Marcos-Gragera R; Kogevinas M; Pollán M; Dierssen-Sotos T
Eur J Med Res; 2023 Nov; 28(1):480. PubMed ID: 37925534
[TBL] [Abstract][Full Text] [Related]
7. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of a five-microRNA signature in breast carcinoma as a promising biomarker for diagnosis.
Bitaraf A; Babashah S; Garshasbi M
J Clin Lab Anal; 2020 Feb; 34(2):e23063. PubMed ID: 31595567
[TBL] [Abstract][Full Text] [Related]
9. Small extracellular vesicle-encapsulated miR-181b-5p, miR-222-3p and let-7a-5p: Next generation plasma biopsy-based diagnostic biomarkers for inflammatory breast cancer.
Ahmed SH; Espinoza-Sánchez NA; El-Damen A; Fahim SA; Badawy MA; Greve B; El-Shinawi M; Götte M; Ibrahim SA
PLoS One; 2021; 16(4):e0250642. PubMed ID: 33901254
[TBL] [Abstract][Full Text] [Related]
10. Association of the peripheral blood levels of circulating microRNAs with both recurrent miscarriage and the outcomes of embryo transfer in an in vitro fertilization process.
Yang Q; Gu WW; Gu Y; Yan NN; Mao YY; Zhen XX; Wang JM; Yang J; Shi HJ; Zhang X; Wang J
J Transl Med; 2018 Jul; 16(1):186. PubMed ID: 29973278
[TBL] [Abstract][Full Text] [Related]
11. Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer.
Zhang J; Song Y; Zhang C; Zhi X; Fu H; Ma Y; Chen Y; Pan F; Wang K; Ni J; Jin W; He X; Su H; Cui D
Theranostics; 2015; 5(7):733-45. PubMed ID: 25897338
[TBL] [Abstract][Full Text] [Related]
12. Circulating microRNAs in association with pancreatic cancer risk within 5 years.
Wang C; Cai H; Cai Q; Wu J; Stolzenberg-Solomon R; Guo X; Zhu C; Gao YT; Berlin J; Ye F; Zheng W; Setiawan VW; Shu XO
Int J Cancer; 2024 Aug; 155(3):519-531. PubMed ID: 38602070
[TBL] [Abstract][Full Text] [Related]
13. The ANDROMEDA prospective cohort study: predictive value of combined criteria to tailor breast cancer screening and new opportunities from circulating markers: study protocol.
Giordano L; Gallo F; Petracci E; Chiorino G; Segnan N;
BMC Cancer; 2017 Nov; 17(1):785. PubMed ID: 29166878
[TBL] [Abstract][Full Text] [Related]
14. Analysis of circulating extracellular vesicle derived microRNAs in breast cancer patients with obesity: a potential role for Let-7a.
Barone I; Gelsomino L; Accattatis FM; Giordano F; Gyorffy B; Panza S; Giuliano M; Veneziani BM; Arpino G; De Angelis C; De Placido P; Bonofiglio D; Andò S; Giordano C; Catalano S
J Transl Med; 2023 Mar; 21(1):232. PubMed ID: 37004031
[TBL] [Abstract][Full Text] [Related]
15. Combined detection of plasma miR-127-3p and HE4 improves the diagnostic efficacy of breast cancer.
Lu M; Ju S; Shen X; Wang X; Jing R; Yang C; Chu H; Cong H
Cancer Biomark; 2017; 18(2):143-148. PubMed ID: 27983524
[TBL] [Abstract][Full Text] [Related]
16. Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis.
Zou X; Wei J; Huang Z; Zhou X; Lu Z; Zhu W; Miao Y
Cancer Med; 2019 Jun; 8(6):2810-2822. PubMed ID: 31006985
[TBL] [Abstract][Full Text] [Related]
17. Underexpression of circulating miR-145-5p and miR-133a-3p are associated with breast cancer and immunohistochemical markers.
García-Magallanes N; Beltran-Ontiveros SA; Leal-León EA; Luque-Ortega F; Romero-Quintana JG; Osuna-Ramirez I; Barbosa-Jasso M; Arámbula-Meraz E
J Cancer Res Ther; 2020; 16(6):1223-1228. PubMed ID: 33342777
[TBL] [Abstract][Full Text] [Related]
18. Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection.
Zhang H; Zou X; Wu L; Zhang S; Wang T; Liu P; Zhu W; Zhu J
Cancer Med; 2020 Feb; 9(3):1230-1241. PubMed ID: 31856390
[TBL] [Abstract][Full Text] [Related]
19. Identification of candidate microRNA markers of endometriosis with the use of next-generation sequencing and quantitative real-time polymerase chain reaction.
Papari E; Noruzinia M; Kashani L; Foster WG
Fertil Steril; 2020 Jun; 113(6):1232-1241. PubMed ID: 32482255
[TBL] [Abstract][Full Text] [Related]
20. A preliminary study of micro-RNAs as minimally invasive biomarkers for the diagnosis of prostate cancer patients.
Giglio S; De Nunzio C; Cirombella R; Stoppacciaro A; Faruq O; Volinia S; Baldassarre G; Tubaro A; Ishii H; Croce CM; Vecchione A
J Exp Clin Cancer Res; 2021 Feb; 40(1):79. PubMed ID: 33622375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
